Abingworth LLP 13D/13G Filings for Sierra Oncology, Inc. (SRRA)

Abingworth LLP 13D and 13G filings for Sierra Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-07-11
4:30 pm
Sale		 2022-07-01 13D Sierra Oncology, Inc.
SRRA		 Abingworth LLP 0
0.000%		 -2,193,626decrease
(Position Closed)		 Filing
2022-03-21
4:52 pm
Unchanged		 2022-03-10 13D Sierra Oncology, Inc.
SRRA		 Abingworth LLP 2,193,626
8.900%		 0
(Unchanged)		 Filing
2022-02-10
5:00 pm
Purchase		 2022-01-31 13D Sierra Oncology, Inc.
SRRA		 Abingworth LLP 2,193,626
11.300%		 150,000increase
(+7.34%)		 Filing
2021-11-05
4:40 pm
Purchase		 2021-11-05 13D Sierra Oncology, Inc.
SRRA		 Abingworth LLP 2,043,626
12.600%		 7,874increase
(+0.39%)		 Filing